If in the DTC/−T2DM group, the cumulative dose of 131I was correlated with NT-proBNP (Figure 1A), cTn I (Figure 1B), and ST2/IL-33R (Figure 1C), in the group of patients with T2DM, the radioactive dose was correlated only with NT-proANP (Figure 6A). This evidence concerns the gene TNNI3 and type 2 diabetes mellitus.